Genetic recombination and its role in the development of the HIV-1 pandemic

AIDS

Volumn 16, Issue SUPPL. 4, 2002, Pages

  Nájera, Rafael ^a   Delgado, Elena ^a   Pérez Alvarez, Lucía ^a   Thomson, Michael M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Circulating recombinant forms; Recombination; Reinfection; Superinfection; Unique recombinant forms

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DOUBLE STRANDED DNA; GAG PROTEIN; GENOMIC RNA; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; POL PROTEIN; RIBONUCLEASE H; TRANSFER RNA; VIRUS ENVELOPE PROTEIN;

BIOLOGY; CELL COUNT; CYTOTOXIC T LYMPHOCYTE; DNA SYNTHESIS; DRUG DESIGN; GENE FREQUENCY; GENE SEQUENCE; GENETIC EPIDEMIOLOGY; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOME ANALYSIS; GEOGRAPHIC DISTRIBUTION; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MOLECULAR EVOLUTION; MOLECULAR MECHANICS; MOSAICISM; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PHYLOGENY; POLYMERIZATION; PREVALENCE; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RNA HYBRIDIZATION; SEQUENCE HOMOLOGY; SUPERINFECTION; SYNCYTIUM; T LYMPHOCYTE; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTANT; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TYPING;

EID: 0036999990     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200216004-00002     Document Type: Review

References (116)

1. Jost S, Bernard MC, Kaiser L, et al. A patient with HIV-1 superinfection. N Engl J Med 2002, 347:731-736.
2. Domingo E. Quasispecies and the implications for virus persistence and escape. Clin Diagn Virol 1998, 10:97-101.
3. Nájera I, Richman DD, Olivares I, et al. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. AIDS Res Hum Retroviruses 1994, 10:1479-1488.
4. Nájera I, Holguín A, Quiñones-Mateu ME, et al. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J Virol 1995, 69:23-31.
5. Hu WS, Temin HM. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci USA 1990, 87:1556-1560.
6. Clavel F, Hoggan MD, Willey RL, Strebel K, Martin MA, Repaske R. Genetic recombination of human immunodeficiency virus. J Virol 1989, 63:1455-1459.
7. Boulerice F, Li XG, Lvovich A, Wainberg MA. Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells. J Virol 1991, 65:5589-5592.
8. Wooley DP, Smith RA, Czajak S, Desrosiers RC. Direct demonstration of retroviral recombination in a rhesus monkey. J Virol 1997, 71:9650-9653.
9. Temin HM. Sex and recombination in retroviruses. Trends Genet 1991, 7:71-74.
10. Tumas KM, Poszgay JM, Avidan N, et al. Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice. Virology 1993, 192:587-595.
11. Ondoa P, Davis D, Willems B, et al. Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally. J Med Virol 2001, 65:765-776.
12. Kellam P, Larder BA. Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance. J Virol 1995, 69:669-674.
13. Moutouh L, Corbeil J, Richman DD. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA 1996, 93:6106-6111.
14. Golovkina TV, Jaffe AB, Ross SR. Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J Virol 1994, 68:5019-5026.
15. Stuhlmann H, Berg P. Homologous recombination of copackaged retrovirus RNAs during reverse transcription. J Virol 1992, 66:2378-2388.
16. Goff SP. Retroviridae: the retroviruses and their replication. In Fields Virology. Edited by Knippe DM, Howley PM, Griffin DE, et al. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1871-1939.
17. Goodrich DW, Duesberg PH. Retroviral recombination during reverse transcription. Proc Natl Acad Sci USA 1990, 87: 2052-2056.
18. Srinivasan A, York D, Jannoun-Nasr R, et al. Generation of hybrid human immunodeficiency virus by homologous recombination. Proc Natl Acad Sci USA 1989, 86:6388-6392.
19. Yu H, Jetzt AE, Ron Y, Preston BD, Dougherty JP. The nature of human immunodeficiency virus type 1 strand transfers. J Biol Chem 1998, 273:28384-28391.
20. Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, Dougherty JP. High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 2000, 74:1234-1240.
21. Zhang J, Tang LY, Li T, Ma Y, Sapp CM. Most retroviral recombinations occur during minus-strand DNA synthesis. J Virol 2000, 74:2313-2322.
22. Coffin JM. Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol 1979, 42: 1-26.
23. Xu H, Boeke JD. High-frequency deletion between homologous sequences during retrotransposition of Ty elements in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1987, 84: 8553-8557.
24. DeStefano JJ, Mallaber LM, Rodríguez-Rodríguez L, Fay PJ, Bambara RA. Requirements for strand transfer between internal regions of heteropolymer templates by human immunodeficiency virus reverse transcriptase. J Virol 1992, 66:6370-6378.
25. Wu W, Blumberg BM, Fay PJ, Bambara RA. Strand transfer mediated by human immunodeficiency virus reverse transcriptase in vitro is promoted by pausing and results in misincorporation. J Biol Chem 1995, 270:325-332.
26. DeStefano JJ, Buiser RG, Mallaber LM, Fay PJ, Bambara RA. Parameters that influence processive synthesis and site-specific termination by human immunodeficiency virus reverse transcriptase on RNA and DNA templates. Biochim Biophys Acta 1992, 1131:270-280.
27. Palaniappan C, Wisniewski M, Wu W, Fay PJ, Bambara RA. Misincorporation by HIV-1 reverse transcriptase promotes recombination via strand transfer synthesis. J Biol Chem 1996, 271:22331-22338.
28. Svarovskaia ES, Delviks KA, Hwang CK, Pathak VK. Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol 2000, 74: 7171-7178.
29. Hwang CK, Svarovskaia ES, Pathak VK. Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching. Proc Natl Acad Sci USA 2001, 98: 12209-12214.
30. Negroni M, Buc H. Retroviral recombination: what drives the switch? Nat Rev Mol Cell Biol 2001, 2:151-155.
31. Kim JK, Palaniappan C, Wu W, Fay PJ, Bambara RA. Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1. J Biol Chem 1997, 272:16769-16777.
32. Mikkelsen JG, Lund AH, Duch M, Pedersen FS. Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo. J Virol 2000, 74:600-610.
33. An W, Telesnitsky A. Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol 2002, 76: 7897-7902.
34. Siepel AC, Halpern AL, Macken C, Korber BT. A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. AIDS Res Hum Retroviruses 1995, 11: 1413-1416.
35. Lole KS, Bollinger RC, Paranjape RS, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999, 73:152-160.
36. Gao F, Robertson DL, Morrison SG, et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996, 70:7013-7029.
37. Gao F, Robertson DL, Carruthers CD, et al. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998, 72:5680-5698.
38. Salminen MO, Carr JK, Burke DS, McCutchan FE. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995, 11:1423-1425.
39. Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol 1995, 40:249-259.
40. Li W-H, Tanimura M, Sharp PM. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol Biol Evol 1988, 5:313-330.
41. Myers G, Korber B, Berzofsky JA, Smith RF, Pavlakis GN. Human Retroviruses and AIDS 1992. Los Alamos, NM: Los Alamos National Laboratory; 1992:III-2-III-4.
42. Louwagie J, McCutchan FE, Peeters M, et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993, 7:769-780.
43. Salminen M, Nykanen A, Brummer-Korvenkontio H, Kantanen ML, Liitsola K, Leinikki P. Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. Virology 1993, 195:185-194.
44. Sabino EC, Shpaer EG, Morgado MG, et al. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol 1994, 68:6340-6346.
45. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature 1995, 374:124-126.
46. Carr JK, Salminen MO, Koch C, et al. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996, 70:5935-5943.
47. Carr JK, Salminen MO, Albert J, et al. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 1998, 247:22-31.
48. Montavon C, Toure-Kane C, Liegeois F, et al. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr 2000, 23:363-374.
49. Carr JK, Torimiro JN, Wolfe ND, et al. The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology 2001, 286:168-181.
50. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science 2000, 288:55-56.
51. Los Alamos National Laboratory. HIV Sequence Database [http://hiv-web.lanl.gov]. Los Alamos, NM: Los Alamos National Laboratory.
52. Peeters M. Recombinant HIV sequences: their role in the global pandemic. In HIV Sequence Compendium 2000. Edited by Kuiken C, Foley B, Hahn B, et al. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 2001:54-72.
53. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002, 29:184-190.
54. Thomson MM, Delgado E, Herrero I, et al. Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol 2002, 83:107-119.
55. Carr JK, Ávila M, Gómez Carrillo M, et al. Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001, 15:F41-F47.
56. Thomson MM, Villahermosa ML, Vázquez-de Parga E, et al. Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina. AIDS 2000, 14:897-899.
57. Thomson MM, Manjón N, Tanuri A, et al. Identification of diverse HIV-1 BF intersubtype recombinant viruses with unique mosaic structures in Brazil. XIV International AIDS Conference. Barcelona, July 2002 [abstract MoPpA2004].
58. Thomson MM, Delgado E, Manjón N, et al. HIV-1 genetic diversity in Galicia, Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS 2001, 15:509-516.
59. Delgado E, Thomson MM, Villahermosa ML, et al. Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J Acquir Immune Defic Syndr 2002, 29:536-543.
60. Esteves A, Parreira R, Venenno T, et al. Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes. AIDS Res Hum Retroviruses 2002, 18:313-325.
61. Montavon C, Toure-Kane C, Nkengasong JN, et al. CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J Acquit Immune Defic Syndr 2002, 29:522-530.
62. Mamadou S, Montavon C, Ben A, et al. Predominance of CRF02-AG and CRF06-cpx in Niger, West Africa. AIDS Res Hum Retroviruses 2002, 18:723-726.
63. Zetterberg V, Ustina V, Liitsola K, et al. CRF06-cpx and subtype A (Eastern European strain) are responsible for the explosive injecting drug use-associated HIV-1 epidemic in Estonia. XIV International AIDS Conference. Barcelona, July 2002 [abstract TuPeC4799].
64. Montavon C, Vergne L, Bourgeois A, et al. Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. AIDS Res Hum Retroviruses 2002, 18:231-236.
65. Paraskevis D, Magiorkinis M, Paparizos V, Pavlakis GN, Hatzakis A. Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences. AIDS Res Hum Retroviruses 2000, 16:845-855.
66. Wilbe K, Casper C, Albert J, Leitner T. Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon. AIDS Res Hum Retroviruses 2000, 18:849-856.
67. Cuevas MT, Ruibal I, Villahermosa ML, et al. High HIV-1 genetic diversity in Cuba. AIDS 2002, 16:1643-1653.
68. Jonassen TO, Grinde B, Asjo B, Hasle G, Hungnes O. Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases. AIDS Res Hum Retroviruses 2000, 16:49-58.
69. Barlow KL, Tatt ID, Cane PA, Pillay D, Clewley JP. Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res Hum Retroviruses 2001, 17:467-474.
70. McCutchan FE, Carr JK, Bajani M, et al. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology 1999, 254:226-234.
71. Vidal N, Peeters M, Mulanga-Kabeya C, et al. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000, 74:10498-10507.
72. Carr JK, Wolfe N, Kim B, Torimiro J, Eitel M, Burke D, et al. Genetic Diversity of HIV-1 strains from rural Cameroon. XIV International AIDS Conference. Barcelona, July 2002 [abstract ThOrA1381].
73. Renjifo B, Gilbert P, Chaplin B, et al. Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region. AIDS 1999, 13:1613-1621.
74. Hoelscher M, Kim B, Maboko L, et al. High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania. AIDS 2001, 15:1461-1470.
75. Dowling WE, Kim B, Mason CJ, et al. Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS 2002, 16:1809-1820.
76. Neilson JR, John GC, Carr JK, et al. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999, 73:4393-4403.
77. Robb ML, McCutchan F, Carr JK, et al. Support of HIV-1 vaccine development in East Africa: sequencing of 96 full-genome sequences from Uganda, Kenya, and Tanzania. AIDS Vaccine 2001. Annecy, September 2001 [abstract 27].
78. Eshleman SH, Gonzales MJ, Becker-Pergola G, et al. Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D. AIDS Res Hum Retroviruses 2002, 18:507-511.
79. Yirrell DL, Kaleebu P, Morgan D, et al. Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda. AIDS 2002, 16:279-286.
80. Motomura K, Kusagawa S, Kato K, et al. Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar. AIDS Res Hum Retroviruses 2000, 16:1831-1843.
81. Yang R, Xia X, Kusagawa S, Zhang C, Ben K, Takebe Y. On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS 2002, 16:1401-1407.
82. Abebe A, Pollakis G, Fontanet AL, et al. Identification of a genetic subcluster of HIV type 1 subtype C (C′) widespread in Ethiopia. AIDS Res Hum Retroviruses 2000, 16:1909-1914.
83. Ports KE, Kalish ML, Lott T, et al. Genetic heterogeneity of the V3 region of the HIV-1 envelope glycoprotein in Brazil. Brazilian Collaborative AIDS Research Group. AIDS 1993, 7:1191-1197.
84. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998, 241:181-188.
85. Holm-Hansen C, Baan E, Asjo B, Pascu FR, Goudsmit J, De Jong JJ. Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region. AIDS Res Hum Retroviruses 2000, 16:867-870.
86. Peeters M, Vincent R, Perret JL, et al. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20:115-121.
87. Abebe A, Demissie D, Goudsmit J, et al. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 1999, 13:1305-1311.
88. Batra M, Tien PC, Shafer RW, Contag CH, Katzenstein DA. HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe. AIDS Res Hum Retroviruses 2000, 16:973-979.
89. Tebit DM, Zekeng L, Kaptue L, Salminen M, Krausslich HG, Herchenroder O. Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. AIDS Res Hum Retroviruses 2002, 18:39-48.
90. Pérez-Álvarez L, Delgado E, Villahermosa ML, et al. Biological characteristics of newly described HIV-1 BG recombinants in Spanish individuals. AIDS 2002, 16:669-672.
91. Pérez-Álvarez L, Delgado E, Villahermosa ML, et al. Biological phenotype of recombinants and non-B primary isolates from Spanish patients. XIV International AIDS Conference. Barcelona, July 2002 [abstract WePpA2090].
92. Casper C, Naver L, Clevestig P, et al. Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes. AIDS Res Hum Retroviruses 2002, 18:343-352.
93. Holm-Hansen C, Grothues D, Rustad S, Rosok B, Pascu FR, Asjo B. Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. AIDS Res Hum Retroviruses 1995, 11:597-603.
94. Ferraro GA, Mello MA, Sutmoller F, et al. Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil. AIDS Res Hum Retroviruses 2001, 17:1241-1247.
95. Shimizu N, Haraguchi Y, Takeuchi Y, Soda Y, Kanbe K, Hoshino H. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein. Virology 1999, 259:324-333.
96. Wang B, Lal RB, Dwyer DE, et al. Molecular and biological interactions between two HIV-1 strains from a coinfected patient reveal the first evidence in favor of viral synergism. Virology 2000, 274:105-119.
97. Blackard JT, Cohen DE, Mayer KH. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consecqueces. Clin Infect Dis 2002, 34:1108-1114.
98. Kim JH, Mosca JD, Vahey Mt, et al. Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cells. AIDS Res Hum Retroviruses 1993, 9:875-882.
99. Kim JH, McLinden RJ, Mosca JD, et al. Transcriptional effects of superinfection of HIV chronically infected T cells: studies in dually infected clones. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:329-342.
100. + cells from asympromatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells. J Gen Virol 1996, 77:2953-2962.
101. Gratton S, Cheynier R, Dumaurier RJ, et al. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc Natl Acad Sci USA 2000, 97:14566-14571.
102. Wei Q, Fultz P. Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS. J Virol 1998, 72:3005-3017.
103. Otten RA, Ellenberger DL, Adams DR, et al. Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model. J Infect Dis 1999, 180:673-684.
104. Jung A, Maier R, Vartanian JP, et al. Multiply infected spleen cells in HIV patients. Nature 2002, 418:144.
105. Angel JB, Kravcik S, Belaskas E, et al. Documentation of HIV-1 superinfection and acceleration of disease progression. Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, January-February 2000 [abstract LB2].
106. Daar ES, Frost SDW, Wang JK, et al. Mixed infection with multidrug resistant (MDR) and wild type HIV strains in primary HIV infection (PHI): Early viral rebound suggest loss of immune control. Ninth Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 2002 [abstract 96].
107. Ramas A, Hu DJ, Nguyen L, et al. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002, 76:7444-7452.
108. Walker B. Presentation of a case of superinfection. Presented at XIV International AIDS Conference. Barcelona, July 2002 [abstract TuOrA1180].
109. Thomson MM, Pérez-Álvarez L, Nájera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002, 2:461-471.
110. Gaschen B, Taylor J, Yusim K, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002, 296:2354-2360.
111. Ho DD, Huang Y. The HIV-1 vaccine race. Cell 2002, 110:135-138.
112. Barouch DH, Kunstman J, Kuroda MJ, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002, 415:335-339
113. Goulder PJ, Brander C, Tang Y, et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001, 412:334-338.
114. Yusim K, Kesmir C, Gaschen B, et al. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 2002, 76:8757-8768.
115. Goulder PJR, Walker BD. HIV-1 superinfection - a word of caution. N Engl J Med 2002, 347:757-758.
116. Altfield M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002, 420:434-439.